UBS Adjusts Price Target on Oscar Health to $20 From $15, Maintains Neutral Rating
Oscar Health (OSCR) has an average rating of hold and mean price target of $18.91, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $20.16, Change: $+0.33, Percent Change: +1.66%